Group 1 - The core viewpoint of the news is that Yirui Technology has experienced a significant stock price increase, with a 10.99% rise over the past five days, closing at 123.58 CNY per share and a total market capitalization of 26.131 billion CNY [1] - Yirui Technology, established on March 7, 2011, and listed on September 18, 2020, specializes in the research, production, sales, and services of digital X-ray detectors [1] - The main revenue composition of Yirui Technology includes 81.21% from detector sales, 7.66% from core component sales, 5.89% from solution/technical services, 4.57% from accessory sales, and 0.66% from rental income [1] Group 2 - Tianhong Fund holds a significant position in Yirui Technology through its Tianhong CSI Pharmaceutical 100A fund, which has 134,000 shares, accounting for 0.99% of the fund's net value, making it the ninth-largest holding [2] - The fund has generated a floating profit of approximately 202,400 CNY today and a total of 1,640,200 CNY during the five-day increase [2] - Tianhong CSI Pharmaceutical 100A was established on June 30, 2015, with a current scale of 690 million CNY, and has reported a year-to-date return of 2.73% and a one-year return of 10.73% [2]
奕瑞科技股价连续5天上涨累计涨幅10.99%,天弘基金旗下1只基金持13.4万股,浮盈赚取164.02万元